Only limited overlap of these expression profiles was observed between SARS-CoV-2 experienced RA-MTX, MS-OCR patients and HCs following first and second vaccination (Figure 3d) indicating that both MTX and OCR affect the specific response profile of CD4+ cTfh subsets. This evidence concerns the gene CD4 and myeloid sarcoma.